Innovation Pilar

The Innovation Pilar aims at fostering new ideas to improve health, well-being and lifestyle of European citizens by supporting healthcare systems. The funded projects in this pilar are multidisciplinary and multi-partners (from academia and industry). They cover large topics going from  lifestyle interventions and nutrition, to brain health and treating chronic diseases, to social care and managing risk of exclusion, to improving healthcare system.

There are two types of projects:

•  Innovation by Ideas: collaborative projects that are solution-driven and bottom-up;
•  Innovation by Design: collaborative projects that are needs-driven and start from a recognised market need or societal problem to deliver tangible results for citizens.

Learn more about “Innovation”

Campus Pilar 

The Campus Pilar aims at building a community of healthcare professionals, researchers and future entrepreneurs based on Innovation and entrepreneuship spirit.  The programme is based on the STELLAR approach: “Spark, Transform, Embrace, Lead, Leap, Amplify and Reward”.

These actions will help students and post-doctoral researchers raise their levels of expertise and employability. They will also support professionals and executives who wish to deepen their knowledge and understanding of healthcare and its industry. This pilar finances initial training and professional courses, MOOCs, Summer Schools etc.

Lear more about “Campus”

Accelerator “Business” Pilar

The EIT Health “Accelerator” pilar  aims at supporting the start-up creation and supporting the start-ups and SMEs’ growth.  in this pilar, several services are proposed including access to Living Labs, Test Beds and Incubators in Europe, access to Market Coach Network and investors networks. A “business Plan Competition – BPC” is organised annually in each CLC to select the most promising start-ups and SMEs. Then, once selected they receive a voucher or grant of 50 000 euros. In 2016, Lyonbiopole has been strongly involved in the organisation of the BPC in France together with Cap Digital. At the end of the Competition, 7 SMEs including ACS Biotech, Diabeloop, Endocontrol and Rheonova (Lyonbiopole’s members) were selected for granting. Learn more

Learn more about “Accelerator”

Focus on CLC France 

The French co-location center, of which headquarters are based in Paris, includes the following partners located in Paris Region and Auvergne-Rhône-Alpes:

Core Partners: Air Liquide, BD, Bull, CEA, le Groupe SEB, INRIA, Inserm, Institut Merieux, Sanofi, Université de Grenoble, Université Pierre et Marie Curie.

Associate Partners: Assistance Publique Hôpitaux de Paris, Association e-seniors, Cap Digital, Danone, Essilor, Grenoble Ecole de Management, Gustave Roussy, Lyonbiopôle, Viseo.

 Learn more about CLC France

*The CLC partners are: Germany/Switzerland, Netherlands,, UK/Ireland, Scandivania, Spain, France and Innostars regions (Portugal, Hungary…)

Since 2012, Lyonbiopole has been forming a strategic alliance with 3 European health clusters – Biocat Catalunya, BioM Bavaria, BioPmed Piemonte – to support biotech SMEs in their internationalization. To this end, they have signed 8 cooperation agreements with organizations acting as “gateways” in target markets such as the US, China, Brazil, Japan, Canada, Australia, South Korea, etc.

More information 

In line with its work on systems medicine, Lyonbiopole has been a partner the CASyM consortium financed by the European Commission under the FP7. This project involves 22 partners and will run for four years. It aims to establish a strategic roadmap for the sustainable, effective introduction of systems medicine in Europe.

The CASyM project results intend to influence future European Commission calls for projects under H2020. Lyonbiopole organised a BIOVISION satellite event in 2013, the first CASyM Stakeholders Conference; 150 experts from 20 countries came to participate in the lectures and 10 round tables. A second networking event was organised on 10 April 2014 in Lyon.

Lyonbiopole is a partner of the ASSET project funded by the European Commission. ASSET brings together 14 partners and aims to develop a method to better respond to the scientific and societal challenges raised by pandemics and related crisis management.

The project is for a period of 4 years (January 2014 to December 2017). Its main objective is to establish knowledge and experience to identify scientific (e. g. implementation of new vaccines or treatments) and societal (e. g. population reactions to vaccination or public authorities’ communication policies) issues raised by epidemics and associated management crises, to explore and locate problems of science in society in generalized epidemics, and to define and test a participatory strategy to address the various issues raised.

More information

The Health2CARE project co-financed by the CIP (Competitiveness & Innovation Programme) of the European Union aims, thanks to a strong regional political commitment, to gather 4 clusters dedicated to different technological and industrial sectors (medical technologies; biotechnologies; micro-nano electronics & software; polymers & composites industry) in order to implement new cross sectoral value chains for personalized medicine industry.

Health2Care objective was to gather in Rhone-Alpes Region different technological and end-users sectors such as biotechnologies, medical devices, plastics processes, nanotechnologies, software, to explore new value chains by an open innovation approach. Clusters involved in this initiative had an important role in boosting this interdisciplinarity  and in-fine to reinforce the competitivity of entreprises, especially SMEs in this emerging sector.

In order to promote the emergence and the growth of innovative solutions, 2 calls for projects were launched between 2014 and 2015 in the framework of Health2care. After having been selected by a European jury, a support was proposed to the most promising projects; this support presented as “vouchers” (grants)  to benefit from the intervention of an exterior service provider (selected in a pre-established list by Health2Care).